ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000263214.1	AKT inhibitor VIII	Pancreatic adenocarcinoma	0.028303261	Resistant
ENSG00000263214.1	AKT inhibitor VIII	Bladder urothelial carcinoma	0.021689538	Sensitive